{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:36:57Z","timestamp":1794278217274,"version":"4.9.0"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/nrneurol.2014.206","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T05:26:42Z","timestamp":1415683602000},"page":"683-693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":359,"title":["'The clocks that time us'\u2014circadian rhythms in neurodegenerative disorders"],"prefix":"10.1038","volume":"10","author":[{"given":"Aleksandar","family":"Videnovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpar S.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Overeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"key":"BFnrneurol2014206_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","volume":"35","author":"JA Mohawk","year":"2012","unstructured":"Mohawk, J. A., Green, C. B. & Takahashi, J. S. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 35, 445\u2013462 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnrneurol2014206_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0006-8993(85)91350-2","volume":"342","author":"DF Swaab","year":"1985","unstructured":"Swaab, D. F., Fliers, E. & Partiman, T. S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342, 37\u201344 (1985).","journal-title":"Brain Res."},{"key":"BFnrneurol2014206_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/074873048800300106","volume":"3","author":"VM Cassone","year":"1988","unstructured":"Cassone, V. M., Speh, J. C., Card, J. P. & Moore, R. Y. Comparative anatomy of the mammalian hypothalamic suprachiasmatic nucleus. J. Biol. Rhythms 3, 71\u201391 (1988).","journal-title":"J. Biol. Rhythms"},{"key":"BFnrneurol2014206_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1152\/physrev.00009.2009","volume":"90","author":"DA Golombek","year":"2010","unstructured":"Golombek, D. A. & Rosenstein, R. E. Physiology of circadian entrainment. Physiol. Rev. 90, 1063\u20131102 (2010).","journal-title":"Physiol. Rev."},{"key":"BFnrneurol2014206_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/07420520701283693","volume":"24","author":"H Dardente","year":"2007","unstructured":"Dardente, H. & Cermakian, N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24, 195\u2013213 (2007).","journal-title":"Chronobiol. Int."},{"key":"BFnrneurol2014206_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-396971-2.00001-4","volume":"119","author":"RY Moore","year":"2013","unstructured":"Moore, R. Y. The suprachiasmatic nucleus and the circadian timing system. Prog. Mol. Biol. Transl. Sci. 119, 1\u201328 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"BFnrneurol2014206_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer's disease. Lancet 377, 1019\u20131031 (2011).","journal-title":"Lancet"},{"key":"BFnrneurol2014206_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner, L. M. & G\u00f6tz, J. Amyloid-\u03b2 and tau-\u2014a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65\u201372 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol2014206_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2014206_CR10","first-page":"108","volume":"6","author":"A Bianchetti","year":"1995","unstructured":"Bianchetti, A. et al. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 6, 108\u2013112 (1995).","journal-title":"Dementia"},{"key":"BFnrneurol2014206_CR11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089198879100400405","volume":"4","author":"CP Pollak","year":"1991","unstructured":"Pollak, C. P. & Perlick, D. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiatry Neurol. 4, 204\u2013210 (1991).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"BFnrneurol2014206_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neurobiolaging.2003.04.009","volume":"25","author":"DG Harper","year":"2004","unstructured":"Harper, D. G. et al. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol. Aging 25, 771\u2013781 (2004).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0197-4580(95)00059-N","volume":"16","author":"A Satlin","year":"1995","unstructured":"Satlin, A., Volicer, L., Stopa, E. G. & Harper, D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol. Aging 16, 765\u2013771 (1995).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00019442-200505000-00004","volume":"13","author":"DG Harper","year":"2005","unstructured":"Harper, D. G. et al. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am. J. Geriatr Psychiatry 13, 359\u2013368 (2005).","journal-title":"Am. J. Geriatr Psychiatry"},{"key":"BFnrneurol2014206_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00702-012-0864-1","volume":"119","author":"EI Most","year":"2012","unstructured":"Most, E. I., Scheltens, P. & Van Someren, E. J. Increased skin temperature in Alzheimer's disease is associated with sleepiness. J. Neural Transm. 119, 1185\u20131194 (2012).","journal-title":"J. Neural Transm."},{"key":"BFnrneurol2014206_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0006-3223(90)90523-5","volume":"27","author":"W Witting","year":"1990","unstructured":"Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M. & Swaab, D. F. Alterations in the circadian rest\u2013activity rhythm in aging and Alzheimer's disease. Biol. Psychiatry 27, 563\u2013572 (1990).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2014206_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-3223(95)00370-3","volume":"40","author":"EJ van Someren","year":"1996","unstructured":"van Someren, E. J. et al. Circadian rest\u2013activity rhythm disturbances in Alzheimer's disease. Biol. Psychiatry 40, 259\u2013270 (1996).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2014206_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.22468","volume":"70","author":"GJ Tranah","year":"2011","unstructured":"Tranah, G. J. et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 70, 722\u2013732 (2011).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2014206_CR19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/brain\/awh129","volume":"127","author":"CF Hatfield","year":"2004","unstructured":"Hatfield, C. F., Herbert, J., van Someren, E. J., Hodges, J. R. & Hastings, M. H. Disrupted daily activity\/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 127, 1061\u20131074 (2004).","journal-title":"Brain"},{"issue":"Suppl. 1","key":"BFnrneurol2014206_CR20","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1007\/s10072-007-0738-8","volume":"28","author":"M Manconi","year":"2007","unstructured":"Manconi, M., Hutchins, W., Feroah, T. R., Zucconi, M. & Ferini-Strambi, L. On the pathway of an animal model for restless legs syndrome. Neurol. Sci. 28 (Suppl. 1), S53\u2013S60 (2007).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2014206_CR21","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1073\/pnas.0806087106","volume":"106","author":"K Hu","year":"2009","unstructured":"Hu, K., Van Someren, E. J., Shea, S. A. & Scheer, F. A. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Proc. Natl Acad. Sci. USA 106, 2490\u20132494 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2014206_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0531-5565(02)00198-5","volume":"38","author":"DJ Skene","year":"2003","unstructured":"Skene, D. J. & Swaab, D. F. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp. Gerontol. 38, 199\u2013206 (2003).","journal-title":"Exp. Gerontol."},{"key":"BFnrneurol2014206_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-079X.2011.00937.x","volume":"52","author":"SA Rosales-Corral","year":"2012","unstructured":"Rosales-Corral, S. A. et al. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J. Pineal Res. 52, 167\u2013202 (2012).","journal-title":"J. Pineal Res."},{"key":"BFnrneurol2014206_CR24","doi-asserted-by":"publisher","first-page":"14575","DOI":"10.3390\/ijms140714575","volume":"14","author":"L Lin","year":"2013","unstructured":"Lin, L. et al. Melatonin in Alzheimer's disease. Int. J. Mol. Sci. 14, 14575\u201314593 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrneurol2014206_CR25","first-page":"323","volume":"84","author":"RY Liu","year":"1999","unstructured":"Liu, R. Y., Zhou, J. N., van Heerikhuize, J., Hofman, M. A. & Swaab, D. F. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-\u03b54\/4 genotype. J. Clin. Endocrinol. Metab. 84, 323\u2013327 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2014206_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","volume":"35","author":"JN Zhou","year":"2003","unstructured":"Zhou, J. N., Liu, R. Y., Kamphorst, W., Hofman, M. A. & Swaab, D. F. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res. 35, 125\u2013130 (2003).","journal-title":"J. Pineal Res."},{"key":"BFnrneurol2014206_CR27","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1210\/jc.2003-030833","volume":"88","author":"YH Wu","year":"2003","unstructured":"Wu, Y. H. et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J. Clin. Endocrinol. Metab. 88, 5898\u20135906 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2014206_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","volume":"45","author":"K Mishima","year":"1999","unstructured":"Mishima, K. et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep\u2013waking. Biol. Psychiatry 45, 417\u2013421 (1999).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2014206_CR29","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2011.12.026","volume":"33","author":"L Shan","year":"2012","unstructured":"Shan, L., Bossers, K., Unmehopa, U., Bao, A. M. & Swaab, D. F. Alterations in the histaminergic system in Alzheimer's disease: a postmortem study. Neurobiol. Aging 33, 2585\u20132598 (2012).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.5665\/sleep.1838","volume":"35","author":"L Shan","year":"2012","unstructured":"Shan, L. et al. Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep 35, 713\u2013715 (2012).","journal-title":"Sleep"},{"key":"BFnrneurol2014206_CR31","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.neurobiolaging.2006.06.002","volume":"28","author":"YH Wu","year":"2007","unstructured":"Wu, Y. H., Zhou, J. N., Van Heerikhuize, J., Jockers, R. & Swaab, D. F. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol. Aging 28, 1239\u20131247 (2007).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00005072-199901000-00004","volume":"58","author":"EG Stopa","year":"1999","unstructured":"Stopa, E. G. et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58, 29\u201339 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2014206_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0306-4522(00)00583-2","volume":"103","author":"AN Coogan","year":"2001","unstructured":"Coogan, A. N., Rawlings, N., Luckman, S. M. & Piggins, H. D. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro. Neuroscience 103, 663\u2013672 (2001).","journal-title":"Neuroscience"},{"key":"BFnrneurol2014206_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0197-4580(95)00043-E","volume":"16","author":"JN Zhou","year":"1995","unstructured":"Zhou, J. N., Hofman, M. A. & Swaab, D. F. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol. Aging 16, 571\u2013576 (1995).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/jnen\/59.4.314","volume":"59","author":"RY Liu","year":"2000","unstructured":"Liu, R. Y. et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59, 314\u2013322 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2014206_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.biopsych.2012.11.021","volume":"74","author":"AN Coogan","year":"2013","unstructured":"Coogan, A. N. et al. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Biol. Psychiatry 74, 333\u2013339 (2013).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2014206_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1017\/S104161029000028X","volume":"2","author":"RP Friedland","year":"1990","unstructured":"Friedland, R. P., Luxenberg, J. S. & Koss, E. A quantitative study of intracranial calcification in dementia of the Alzheimer type. Int. Psychogeriatr. 2, 36\u201343 (1990).","journal-title":"Int. Psychogeriatr."},{"key":"BFnrneurol2014206_CR38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1096\/fj.05-4446fje","volume":"20","author":"YH Wu","year":"2006","unstructured":"Wu, Y. H. et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the \u201cmaster clock\u201d. FASEB J. 20, 1874\u20131876 (2006).","journal-title":"FASEB J."},{"key":"BFnrneurol2014206_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0748730410395732","volume":"26","author":"N Cermakian","year":"2011","unstructured":"Cermakian, N., Lamont, E. W., Boudreau, P. & Boivin, D. B. Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects. J. Biol. Rhythms 26, 160\u2013170 (2011).","journal-title":"J. Biol. Rhythms"},{"key":"BFnrneurol2014206_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk, R., Dyck, R. H., Laferla, F. M. & Antle, M. C. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res. 1348, 139\u2013148 (2010).","journal-title":"Brain Res."},{"key":"BFnrneurol2014206_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1242\/dmm.010173","volume":"6","author":"EM Knight","year":"2013","unstructured":"Knight, E. M. et al. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice. Dis. Model Mech. 6, 160\u2013170 (2013).","journal-title":"Dis. Model Mech."},{"key":"BFnrneurol2014206_CR42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3109\/07420528.2010.485711","volume":"27","author":"MR Gorman","year":"2010","unstructured":"Gorman, M. R. & Yellon, S. Lifespan daily locomotor activity rhythms in a mouse model of amyloid-induced neuropathology. Chronobiol. Int. 27, 1159\u20131177 (2010).","journal-title":"Chronobiol. Int."},{"key":"BFnrneurol2014206_CR43","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuroscience.2004.11.018","volume":"131","author":"JP Wisor","year":"2005","unstructured":"Wisor, J. P. et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 131, 375\u2013385 (2005).","journal-title":"Neuroscience"},{"key":"BFnrneurol2014206_CR44","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neurobiolaging.2005.05.009","volume":"27","author":"O Ambree","year":"2006","unstructured":"Ambree, O. et al. Activity changes and marked stereotypic behavior precede A\u03b2 pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging 27, 955\u2013964 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.arr.2012.04.003","volume":"12","author":"D Slats","year":"2013","unstructured":"Slats, D., Claassen, J. A., Verbeek, M. M. & Overeem, S. Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: focus on the role of hypocretin and melatonin. Ageing Res. Rev. 12, 188\u2013200 (2013).","journal-title":"Ageing Res. Rev."},{"key":"BFnrneurol2014206_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1745-7254.2006.00260.x","volume":"27","author":"JZ Wang","year":"2006","unstructured":"Wang, J. Z. & Wang, Z. F. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol. Sin. 27, 41\u201349 (2006).","journal-title":"Acta Pharmacol. Sin."},{"key":"BFnrneurol2014206_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YE Ju","year":"2014","unstructured":"Ju, Y. E., Lucey, B. P. & Holtzman, D. M. Sleep and Alzheimer disease pathology\u2014a bidirectional relationship. Nat. Rev. Neurol. 10, 115\u2013119 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2014206_CR48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang, J. E. et al. Amyloid-\u03b2 dynamics are regulated by orexin and the sleep\u2013wake cycle. Science 326, 1005\u20131007 (2009).","journal-title":"Science"},{"key":"BFnrneurol2014206_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373\u2013377 (2013).","journal-title":"Science"},{"key":"BFnrneurol2014206_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","volume":"71","author":"S Ooms","year":"2014","unstructured":"Ooms, S. et al. Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 71, 971\u2013977 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2014206_CR51","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1074\/jbc.273.13.7185","volume":"273","author":"M Pappolla","year":"1998","unstructured":"Pappolla, M. et al. Inhibition of Alzheimer \u03b2-fibrillogenesis by melatonin. J. Biol. Chem. 273, 7185\u20137188 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2014206_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1600-079X.2004.00121.x","volume":"36","author":"DK Lahiri","year":"2004","unstructured":"Lahiri, D. K., Chen, D., Ge, Y. W., Bondy, S. C. & Sharman, E. H. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J. Pineal Res. 36, 224\u2013231 (2004).","journal-title":"J. Pineal Res."},{"key":"BFnrneurol2014206_CR53","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","volume":"85","author":"E Matsubara","year":"2003","unstructured":"Matsubara, E. et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J. Neurochem. 85, 1101\u20131108 (2003).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2014206_CR54","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1272\/jnms.70.334","volume":"70","author":"K Asayama","year":"2003","unstructured":"Asayama, K. et al. Double blind study of melatonin effects on the sleep\u2013wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J. Nippon Med. Sch. 70, 334\u2013341 (2003).","journal-title":"J. Nippon Med. Sch."},{"key":"BFnrneurol2014206_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157015910792246209","volume":"8","author":"DP Cardinali","year":"2010","unstructured":"Cardinali, D. P., Furio, A. M. & Brusco, L. I. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr. Neuropharmacol. 8, 218\u2013227 (2010).","journal-title":"Curr. Neuropharmacol."},{"key":"BFnrneurol2014206_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","volume":"56","author":"GA Dowling","year":"2008","unstructured":"Dowling, G. A. et al. Melatonin and bright-light treatment for rest\u2013activity disruption in institutionalized patients with Alzheimer's disease. J. Am. Geriatr Soc. 56, 239\u2013246 (2008).","journal-title":"J. Am. Geriatr Soc."},{"key":"BFnrneurol2014206_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00391-007-0420-z","volume":"40","author":"R Mahlberg","year":"2007","unstructured":"Mahlberg, R. & Walther, S. Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. Z. Gerontol. Geriatr. 40, 178\u2013184 (2007).","journal-title":"Z. Gerontol. Geriatr."},{"key":"BFnrneurol2014206_CR58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","volume":"26","author":"C Singer","year":"2003","unstructured":"Singer, C. et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26, 893\u2013901 (2003).","journal-title":"Sleep"},{"key":"BFnrneurol2014206_CR59","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/JGP.0b013e318187de18","volume":"17","author":"PR Gehrman","year":"2009","unstructured":"Gehrman, P. R. et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am. J. Geriatr Psychiatry 17, 166\u2013169 (2009).","journal-title":"Am. J. Geriatr Psychiatry"},{"key":"BFnrneurol2014206_CR60","doi-asserted-by":"publisher","unstructured":"Jansen, S. L., Forbes, D. A., Duncan, V. & Morgan, D. G. Melatonin for cognitive impairment. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003802. http:\/\/dx.doi.org\/10.1002\/14651858.CD003802.pub3 .","DOI":"10.1002\/14651858.CD003802.pub3"},{"key":"BFnrneurol2014206_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<520::AID-GPS983>3.0.CO;2-M","volume":"14","author":"CG Lyketsos","year":"1999","unstructured":"Lyketsos, C. G., Lindell Veiel, L., Baker, A. & Steele, C. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int. J. Geriatr Psychiatry 14, 520\u2013525 (1999).","journal-title":"Int. J. Geriatr Psychiatry"},{"key":"BFnrneurol2014206_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1207\/S15402010BSM0101_4","volume":"1","author":"S Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel, S. et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav. Sleep Med. 1, 22\u201336 (2003).","journal-title":"Behav. Sleep Med."},{"key":"BFnrneurol2014206_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1017\/S1041610209008886","volume":"21","author":"A Burns","year":"2009","unstructured":"Burns, A., Allen, H., Tomenson, B., Duignan, D. & Byrne, J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int. Psychogeriatr. 21, 711\u2013721 (2009).","journal-title":"Int. Psychogeriatr."},{"key":"BFnrneurol2014206_CR64","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1532-5415.2011.03519.x","volume":"59","author":"SM McCurry","year":"2011","unstructured":"McCurry, S. M. et al. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J. Am. Geriatr. Soc. 59, 1393\u20131402 (2011).","journal-title":"J. Am. Geriatr. Soc."},{"key":"BFnrneurol2014206_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1017\/S1041610205001584","volume":"17","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A. et al. Effect of morning bright light treatment for rest\u2013activity disruption in institutionalized patients with severe Alzheimer's disease. Int. Psychogeriatr. 17, 221\u2013236 (2005).","journal-title":"Int. Psychogeriatr."},{"key":"BFnrneurol2014206_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/gps.1352","volume":"20","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A., Mastick, J., Hubbard, E. M., Luxenberg, J. S. & Burr, R. L. Effect of timed bright light treatment for rest\u2013activity disruption in institutionalized patients with Alzheimer's disease. Int. J. Geriatr. Psychiatry 20, 738\u2013743 (2005).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"Suppl. 5","key":"BFnrneurol2014206_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","volume":"255","author":"G Alves","year":"2008","unstructured":"Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz Gjerstad, M. & Larsen, J. P. Epidemiology of Parkinson's disease. J. Neurol. 255 (Suppl. 5), 18\u201332 (2008).","journal-title":"J. Neurol."},{"key":"BFnrneurol2014206_CR68","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey, E. R. et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384\u2013386 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol2014206_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","volume":"25","author":"B Bruguerolle","year":"2002","unstructured":"Bruguerolle, B. & Simon, N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 25, 194\u2013201 (2002).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol2014206_CR70","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1515\/REVNEURO.2008.19.4-5.245","volume":"19","author":"GL Willis","year":"2008","unstructured":"Willis, G. L. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev. Neurosci. 19, 245\u2013316 (2008).","journal-title":"Rev. Neurosci."},{"key":"BFnrneurol2014206_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","volume":"243","author":"A Videnovic","year":"2013","unstructured":"Videnovic, A. & Golombek, D. Circadian and sleep disorders in Parkinson's disease. Exp. Neurol. 243, 45\u201356 (2013).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2014206_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00002826-200001000-00006","volume":"23","author":"U Bonuccelli","year":"2000","unstructured":"Bonuccelli, U. et al. Diurnal motor variations to repeated doses of levodopa in Parkinson's disease. Clin. Neuropharmacol. 23, 28\u201333 (2000).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol2014206_CR73","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jnnp.52.4.481","volume":"52","author":"JG Nutt","year":"1989","unstructured":"Nutt, J. G., Woodward, W. R., Carter, J. H. & Trotman, T. L. Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa. J. Neurol. Neurosurg. Psychiatry 52, 481\u2013487 (1989).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2014206_CR74","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1600-0404.1993.tb04096.x","volume":"87","author":"JJ van Hilten","year":"1993","unstructured":"van Hilten, J. J. et al. Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring. Acta Neurol. Scand. 87, 171\u2013177 (1993).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2014206_CR75","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/jnnp.54.11.976","volume":"54","author":"JJ van Hilten","year":"1991","unstructured":"van Hilten, J. J., Middelkoop, H. A., Kerkhof, G. A. & Roos, R. A. A new approach in the assessment of motor activity in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 54, 976\u2013979 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2014206_CR76","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1600-0404.2006.00580.x","volume":"113","author":"E Mihci","year":"2006","unstructured":"Mihci, E., Kardelen, F., Dora, B. & Balkan, S. Orthostatic heart rate variability analysis in idiopathic Parkinson's disease. Acta Neurol. Scand. 113, 288\u2013293 (2006).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2014206_CR77","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1586\/14737175.6.8.1173","volume":"6","author":"A Pathak","year":"2006","unstructured":"Pathak, A. & Senard, J. M. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev. Neurother. 6, 1173\u20131180 (2006).","journal-title":"Expert Rev. Neurother."},{"key":"BFnrneurol2014206_CR78","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00415-002-0884-0","volume":"249","author":"V Pursiainen","year":"2002","unstructured":"Pursiainen, V. et al. Circadian heart rate variability in Parkinson's disease. J. Neurol. 249, 1535\u20131540 (2002).","journal-title":"J. Neurol."},{"issue":"Suppl. 17","key":"BFnrneurol2014206_CR79","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1002\/mds.21682","volume":"22","author":"CL Comella","year":"2007","unstructured":"Comella, C. L. Sleep disorders in Parkinson's disease: an overview. Mov Disord. 22 (Suppl. 17), S367\u2013S373 (2007).","journal-title":"Mov Disord."},{"key":"BFnrneurol2014206_CR80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-1331.2007.01998.x","volume":"15","author":"B Porter","year":"2008","unstructured":"Porter, B., Macfarlane, R. & Walker, R. The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease. Eur. J. Neurol. 15, 50\u201354 (2008).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2014206_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mds.21727","volume":"23","author":"D Verbaan","year":"2008","unstructured":"Verbaan, D., van Rooden, S. M., Visser, M., Marinus, J. & van Hilten, J. J. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov. Disord. 23, 35\u201341 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR82","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1212\/WNL.40.3_Part_1.467","volume":"40","author":"LK Struck","year":"1990","unstructured":"Struck, L. K., Rodnitzky, R. L. & Dobson, J. K. Circadian fluctuations of contrast sensitivity in Parkinson's disease. Neurology 40, 467\u2013470 (1990).","journal-title":"Neurology"},{"key":"BFnrneurol2014206_CR83","first-page":"219","volume":"61","author":"P Piccini","year":"1991","unstructured":"Piccini, P. et al. Diurnal worsening in Parkinson patients treated with levodopa [Italian]. Riv. Neurol. 61, 219\u2013224 (1991).","journal-title":"Riv. Neurol."},{"key":"BFnrneurol2014206_CR84","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/archneur.1994.00540210094018","volume":"51","author":"B van Hilten","year":"1994","unstructured":"van Hilten, B. et al. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch. Neurol. 51, 922\u2013928 (1994).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2014206_CR85","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/mds.22057","volume":"23","author":"DL Whitehead","year":"2008","unstructured":"Whitehead, D. L., Davies, A. D., Playfer, J. R. & Turnbull, C. J. Circadian rest\u2013activity rhythm is altered in Parkinson's disease patients with hallucinations. Mov. Disord. 23, 1137\u20131145 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR86","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1046\/j.1468-1331.2000.00127.x","volume":"7","author":"M Kallio","year":"2000","unstructured":"Kallio, M. et al. Heart rate variability in patients with untreated Parkinson's disease. Eur. J. Neurol. 7, 667\u2013672 (2000).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2014206_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01819664","volume":"2","author":"JM Senard","year":"1992","unstructured":"Senard, J. M., Chamontin, B., Rascol, A. & Montastruc, J. L. Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin. Auton. Res. 2, 99\u2013104 (1992).","journal-title":"Clin. Auton. Res."},{"key":"BFnrneurol2014206_CR88","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00702-003-0016-8","volume":"110","author":"D Devos","year":"2003","unstructured":"Devos, D. et al. Heart rate variability and Parkinson's disease severity. J. Neural Transm. 110, 997\u20131011 (2003).","journal-title":"J. Neural Transm."},{"issue":"Suppl. 2","key":"BFnrneurol2014206_CR89","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi, K. & Takahashi, H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur. Neurol. 38 (Suppl. 2), 2\u20137 (1997).","journal-title":"Eur. Neurol."},{"key":"BFnrneurol2014206_CR90","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ana.410030207","volume":"3","author":"J Langston","year":"1978","unstructured":"Langston, J. The hypothalamus in Parkinson's disease. Ann. Neurol. 3, 129\u2013133 (1978).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2014206_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0304-3940(84)90323-9","volume":"45","author":"A Wirz-Justice","year":"1984","unstructured":"Wirz-Justice, A., Da Prada, M. & Reme, C. Circadian rhythm in rat retinal dopamine. Neurosci. Lett. 45, 21\u201325 (1984).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2014206_CR92","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1471-4159.1986.tb00612.x","volume":"46","author":"A Dearry","year":"1986","unstructured":"Dearry, A. & Burnside, B. Dopaminergic regulation of cone retinomotor movement in isolated teleost retinas: I. Induction of cone contraction is mediated by D2 receptors. J. Neurochem. 46, 1006\u20131021 (1986).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2014206_CR93","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/revneuro-2013-0002","volume":"24","author":"A Raggi","year":"2013","unstructured":"Raggi, A., Bella, R., Pennisi, G., Neri, W. & Ferri, R. Sleep disorders in Parkinson's disease: a narrative review of the literature. Rev. Neurosci. 24, 279\u2013291 (2013).","journal-title":"Rev. Neurosci."},{"key":"BFnrneurol2014206_CR94","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak, H. & Del Tredici, K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70, 1916\u20131925 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2014206_CR95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","volume":"26","author":"R Bordet","year":"2003","unstructured":"Bordet, R. et al. Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin. Neuropharmacol. 26, 65\u201372 (2003).","journal-title":"Clin. Neuropharmacol."},{"key":"BFnrneurol2014206_CR96","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02257677","volume":"5","author":"E Fertl","year":"1993","unstructured":"Fertl, E., Auff, E., Doppelbauer, A. & Waldhauser, F. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J. Neural Transm. Park. Dis. Dement. Sect. 5, 227\u2013234 (1993).","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"BFnrneurol2014206_CR97","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0197-4580(97)80309-0","volume":"18","author":"A Hartmann","year":"1997","unstructured":"Hartmann, A., Veldhuis, J. D., Deuschle, M., Standhardt, H. & Heuser, I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18, 285\u2013289 (1997).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2014206_CR98","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2826.2011.02134.x","volume":"23","author":"NA Aziz","year":"2011","unstructured":"Aziz, N. A., Pijl, H., Frolich, M., Roelfsema, F. & Roos, R. A. Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J. Neuroendocrinol. 23, 519\u2013524 (2011).","journal-title":"J. Neuroendocrinol."},{"key":"BFnrneurol2014206_CR99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/mds.1039","volume":"16","author":"G Pierangeli","year":"2001","unstructured":"Pierangeli, G. et al. Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy. Mov. Disord. 16, 226\u2013232 (2001).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR100","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/0024-3205(90)90499-H","volume":"46","author":"A Cagnacci","year":"1990","unstructured":"Cagnacci, A. et al. Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. Life Sci. 46, 1241\u20131247 (1990).","journal-title":"Life Sci."},{"key":"BFnrneurol2014206_CR101","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000119735","volume":"56","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K. et al. Circadian variation of core body temperature in Parkinson disease patients with depression: a potential biological marker for depression in Parkinson disease. Neuropsychobiology 56, 172\u2013179 (2007).","journal-title":"Neuropsychobiology"},{"key":"BFnrneurol2014206_CR102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic, A. et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 71, 463\u2013469 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2014206_CR103","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","volume":"71","author":"DP Breen","year":"2014","unstructured":"Breen, D. P. et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589\u2013595 (2014).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2014206_CR104","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","volume":"15","author":"SJ Bolitho","year":"2014","unstructured":"Bolitho, S. J. et al. Disturbances in melatonin secretion and circadian sleep\u2013wake regulation in Parkinson disease. Sleep Med. 15, 342\u2013347 (2014).","journal-title":"Sleep Med."},{"key":"BFnrneurol2014206_CR105","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2003-03-0779","volume":"102","author":"DB Boivin","year":"2003","unstructured":"Boivin, D. B. et al. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102, 4143\u20134145 (2003).","journal-title":"Blood"},{"key":"BFnrneurol2014206_CR106","doi-asserted-by":"publisher","first-page":"R1273","DOI":"10.1152\/ajpregu.00126.2005","volume":"289","author":"M Takimoto","year":"2005","unstructured":"Takimoto, M. et al. Daily expression of clock genes in whole blood cells in healthy subjects and a patient with circadian rhythm sleep disorder. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1273\u2013R1279 (2005).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneurol2014206_CR107","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00109-005-0697-6","volume":"83","author":"M Teboul","year":"2005","unstructured":"Teboul, M. et al. Atypical patterns of circadian clock gene expression in human peripheral blood mononuclear cells. J. Mol. Med. 83, 693\u2013699 (2005).","journal-title":"J. Mol. Med."},{"key":"BFnrneurol2014206_CR108","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1468-1331.2009.02848.x","volume":"17","author":"Y Cai","year":"2009","unstructured":"Cai, Y., Liu, S., Sothern, R. B., Xu, S. & Chan, P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol. 17, 550\u2013554 (2009).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2014206_CR109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky, P. Dopamine and retinal function. Doc. Ophthalmol. 108, 17\u201340 (2004).","journal-title":"Doc. Ophthalmol."},{"key":"BFnrneurol2014206_CR110","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/0024-3205(74)90024-1","volume":"15","author":"LE Harrell","year":"1974","unstructured":"Harrell, L. E. & Balagura, S. The effects of dark and light on the functional recovery following lateral hypothalamic lesions. Life Sci. 15, 2079\u20132087 (1974).","journal-title":"Life Sci."},{"key":"BFnrneurol2014206_CR111","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/07420520701420717","volume":"24","author":"GL Willis","year":"2007","unstructured":"Willis, G. L. & Turner, E. J. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24, 521\u2013537 (2007).","journal-title":"Chronobiol. Int."},{"key":"BFnrneurol2014206_CR112","first-page":"199","volume":"23","author":"GL Willis","year":"2012","unstructured":"Willis, G. L., Moore, C. & Armstrong, S. M. A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease. Rev. Neurosci. 23, 199\u2013226 (2012).","journal-title":"Rev. Neurosci."},{"key":"BFnrneurol2014206_CR113","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mds.21542","volume":"22","author":"S Paus","year":"2007","unstructured":"Paus, S. et al. Bright light therapy in Parkinson's disease: a pilot study. Mov. Disord. 22, 1495\u20131498 (2007).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR114","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.expneurol.2009.07.019","volume":"219","author":"Q Barraud","year":"2009","unstructured":"Barraud, Q. et al. Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp. Neurol. 219, 574\u2013582 (2009).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2014206_CR115","doi-asserted-by":"publisher","first-page":"e86240","DOI":"10.1371\/journal.pone.0086240","volume":"9","author":"K Fifel","year":"2014","unstructured":"Fifel, K. et al. Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS ONE 9, e86240 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR116","doi-asserted-by":"publisher","first-page":"e23952","DOI":"10.1371\/journal.pone.0023952","volume":"6","author":"J Vezoli","year":"2011","unstructured":"Vezoli, J. et al. Early presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson's disease. PLoS ONE 6, e23952 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR117","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0024-3205(00)00751-7","volume":"67","author":"V Ben","year":"2000","unstructured":"Ben, V. & Bruguerolle, B. Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci. 67, 1549\u20131558 (2000).","journal-title":"Life Sci."},{"key":"BFnrneurol2014206_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0006-8993(01)02223-5","volume":"899","author":"Y Isobe","year":"2001","unstructured":"Isobe, Y. & Nishino, H. Circadian rhythm of drinking and running-wheel activity in rats with 6-hydroxydopamine lesions of the ventral tegmental area. Brain Res. 899, 187\u2013192 (2001).","journal-title":"Brain Res."},{"key":"BFnrneurol2014206_CR119","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00221-005-0343-0","volume":"169","author":"PC Baier","year":"2006","unstructured":"Baier, P. C. et al. Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats. Exp. Brain Res. 169, 283\u2013288 (2006).","journal-title":"Exp. Brain Res."},{"key":"BFnrneurol2014206_CR120","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12031-011-9520-8","volume":"45","author":"L Gravotta","year":"2011","unstructured":"Gravotta, L., Gavrila, A. M., Hood, S. & Amir, S. Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. J. Mol. Neurosci. 45, 162\u2013171 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrneurol2014206_CR121","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2011.08.003","volume":"232","author":"T Kudo","year":"2011","unstructured":"Kudo, T., Loh, D. H., Truong, D., Wu, Y. & Colwell, C. S. Circadian dysfunction in a mouse model of Parkinson's disease. Exp. Neurol. 232, 66\u201375 (2011).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2014206_CR122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.expneurol.2013.01.014","volume":"243","author":"LD Willison","year":"2013","unstructured":"Willison, L. D., Kudo, T., Loh, D. H., Kuljis, D. & Colwell, C. S. Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model. Exp. Neurol. 243, 57\u201366 (2013).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2014206_CR123","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S1474-4422(10)70287-8","volume":"9","author":"PJ Morrison","year":"2010","unstructured":"Morrison, P. J. Accurate prevalence and uptake of testing for Huntington's disease. Lancet Neurol. 9, 1147 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2014206_CR124","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF00194305","volume":"89","author":"PS Harper","year":"1992","unstructured":"Harper, P. S. The epidemiology of Huntington's disease. Hum. Genet. 89, 365\u2013376 (1992).","journal-title":"Hum. Genet."},{"key":"BFnrneurol2014206_CR125","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell, R. G. et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4, 393\u2013397 (1993).","journal-title":"Nat. Genet."},{"key":"BFnrneurol2014206_CR126","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella, J. F. et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306, 234\u2013238 (1983).","journal-title":"Nature"},{"key":"BFnrneurol2014206_CR127","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.2890209","volume":"238","author":"TC Gilliam","year":"1987","unstructured":"Gilliam, T. C. et al. A DNA segment encoding two genes very tightly linked to Huntington's disease. Science 238, 950\u2013952 (1987).","journal-title":"Science"},{"key":"BFnrneurol2014206_CR128","doi-asserted-by":"crossref","unstructured":"[No authors listed] A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"BFnrneurol2014206_CR129","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1212\/WNL.45.10.1867","volume":"45","author":"KA Bamford","year":"1995","unstructured":"Bamford, K. A., Caine, E. D., Kido, D. K., Cox, C. & Shoulson, I. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology 45, 1867\u20131873 (1995).","journal-title":"Neurology"},{"key":"BFnrneurol2014206_CR130","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S. & Cummings, J. L. Neuropsychiatric aspects of Huntington's disease. J. Neurol. Neurosurg. Psychiatry 71, 310\u2013314 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2014206_CR131","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/1531-8249(200007)48:1<130::AID-ANA27>3.0.CO;2-8","volume":"48","author":"N Stoy","year":"2000","unstructured":"Stoy, N. & McKay, E. Weight loss in Huntington's disease. Ann. Neurol. 48, 130\u2013131 (2000).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2014206_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11910-010-0163-x","volume":"11","author":"AO Goodman","year":"2011","unstructured":"Goodman, A. O. et al. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease. Curr. Neurol. Neurosci. Rep. 11, 211\u2013217 (2011).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneurol2014206_CR133","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/WNL.35.11.1672","volume":"35","author":"P Hansotia","year":"1985","unstructured":"Hansotia, P., Wall, R. & Berendes, J. Sleep disturbances and severity of Huntington's disease. Neurology 35, 1672\u20131674 (1985).","journal-title":"Neurology"},{"key":"BFnrneurol2014206_CR134","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF00314313","volume":"235","author":"W Emser","year":"1988","unstructured":"Emser, W., Brenner, M., Stober, T. & Schimrigk, K. Changes in nocturnal sleep in Huntington's and Parkinson's disease. J. Neurol. 235, 177\u2013179 (1988).","journal-title":"J. Neurol."},{"key":"BFnrneurol2014206_CR135","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0987-7053(96)81034-3","volume":"25","author":"R Silvestri","year":"1995","unstructured":"Silvestri, R. et al. Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea. Neurophysiol. Clin. 25, 66\u201377 (1995).","journal-title":"Neurophysiol. Clin."},{"key":"BFnrneurol2014206_CR136","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/15402000903190215","volume":"7","author":"M Cuturic","year":"2009","unstructured":"Cuturic, M., Abramson, R. K., Vallini, D., Frank, E. M. & Shamsnia, M. Sleep patterns in patients with Huntington's disease and their unaffected first-degree relatives: a brief report. Behav. Sleep Med. 7, 245\u2013254 (2009).","journal-title":"Behav. Sleep Med."},{"key":"BFnrneurol2014206_CR137","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneur.65.4.482","volume":"65","author":"I Arnulf","year":"2008","unstructured":"Arnulf, I. et al. Rapid eye movement sleep disturbances in Huntington disease. Arch. Neurol. 65, 482\u2013488 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2014206_CR138","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","volume":"25","author":"AJ Morton","year":"2005","unstructured":"Morton, A. J. et al. Disintegration of the sleep\u2013wake cycle and circadian timing in Huntington's disease. J. Neurosci. 25, 157\u2013163 (2005).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2014206_CR139","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","volume":"228","author":"T Kudo","year":"2011","unstructured":"Kudo, T. et al. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp. Neurol. 228, 80\u201390 (2011).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2014206_CR140","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/07420528.2011.641193","volume":"29","author":"AS Lazar","year":"2012","unstructured":"Lazar, A. S. et al. Sleep, diurnal preference, health, and psychological well-being: a prospective single-allelic-variation study. Chronobiol. Int. 29, 131\u2013146 (2012).","journal-title":"Chronobiol. Int."},{"key":"BFnrneurol2014206_CR141","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/nmt.11.45","volume":"1","author":"EA Epping","year":"2011","unstructured":"Epping, E. A. & Paulsen, J. S. Depression in the early stages of Huntington disease. Neurodegener. Dis. Manag. 1, 407\u2013414 (2011).","journal-title":"Neurodegener. Dis. Manag."},{"key":"BFnrneurol2014206_CR142","doi-asserted-by":"publisher","first-page":"RRN1189","DOI":"10.1371\/currents.RRN1189","volume":"2","author":"AO Goodman","year":"2010","unstructured":"Goodman, A. O., Morton, A. J. & Barker, R. A. Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire. PLoS Curr. 2, RRN1189 (2010).","journal-title":"PLoS Curr."},{"key":"BFnrneurol2014206_CR143","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.parkreldis.2010.02.009","volume":"16","author":"NA Aziz","year":"2010","unstructured":"Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J. & Roos, R. A. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat. Disord. 16, 345\u2013350 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol2014206_CR144","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1192\/bjp.171.4.393c","volume":"171","author":"N Taylor","year":"1997","unstructured":"Taylor, N. & Bramble, D. Sleep disturbance and Huntingdon's disease. Br. J. Psychiatry 171, 393 (1997).","journal-title":"Br. J. Psychiatry"},{"key":"BFnrneurol2014206_CR145","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.parkreldis.2008.10.002","volume":"15","author":"A Videnovic","year":"2009","unstructured":"Videnovic, A., Leurgans, S., Fan, W., Jaglin, J. & Shannon, K. M. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat. Disord. 15, 471\u2013474 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol2014206_CR146","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/brain\/90.3.545","volume":"90","author":"A Starr","year":"1967","unstructured":"Starr, A. A disorder of rapid eye movements in Huntington's chorea. Brain 90, 545\u2013564 (1967).","journal-title":"Brain"},{"key":"BFnrneurol2014206_CR147","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00314781","volume":"238","author":"M Wiegand","year":"1991","unstructured":"Wiegand, M. et al. Nocturnal sleep in Huntington's disease. J. Neurol. 238, 203\u2013208 (1991).","journal-title":"J. Neurol."},{"key":"BFnrneurol2014206_CR148","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/mds.870110406","volume":"11","author":"JP van Vugt","year":"1996","unstructured":"van Vugt, J. P., van Hilten, B. J. & Roos, R. A. Hypokinesia in Huntington's disease. Mov. Disord. 11, 384\u2013388 (1996).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR149","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/mds.1097","volume":"16","author":"JP van Vugt","year":"2001","unstructured":"van Vugt, J. P. et al. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease. Mov. Disord. 16, 481\u2013488 (2001).","journal-title":"Mov. Disord."},{"key":"BFnrneurol2014206_CR150","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00415-005-0709-z","volume":"252","author":"CB Hurelbrink","year":"2005","unstructured":"Hurelbrink, C. B., Lewis, S. J. & Barker, R. A. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep\u2013wake activity in patients with mild-moderate Huntington's disease. J. Neurol. 252, 642\u2013647 (2005).","journal-title":"J. Neurol."},{"key":"BFnrneurol2014206_CR151","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi, M. A., Morton, A. J. & Hayden, M. R. Choosing an animal model for the study of Huntington's disease. Nat. Rev. Neurosci. 14, 708\u2013721 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrneurol2014206_CR152","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","volume":"38","author":"CA Shirbin","year":"2013","unstructured":"Shirbin, C. A. et al. Cortisol and depression in pre-diagnosed and early stage Huntington's disease. Psychoneuroendocrinology 38, 2439\u20132447 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrneurol2014206_CR153","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/brain\/awt128","volume":"136","author":"S Kantor","year":"2013","unstructured":"Kantor, S., Szabo, L., Varga, J., Cuesta, M. & Morton, A. J. Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation. Brain 136, 2147\u20132158 (2013).","journal-title":"Brain"},{"key":"BFnrneurol2014206_CR154","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/brain\/awt132","volume":"136","author":"SP Fisher","year":"2013","unstructured":"Fisher, S. P. et al. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington's disease. Brain 136, 2159\u20132172 (2013).","journal-title":"Brain"},{"key":"BFnrneurol2014206_CR155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/JMN\/31:02:139","volume":"31","author":"J Fahrenkrug","year":"2007","unstructured":"Fahrenkrug, J., Popovic, N., Georg, B., Brundin, P. & Hannibal, J. Decreased VIP and VPAC2 receptor expression in the biological clock of the R6\/2 Huntington's disease mouse. J. Mol. Neurosci. 31, 139\u2013148 (2007).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrneurol2014206_CR156","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbr.2009.04.034","volume":"203","author":"O Rudenko","year":"2009","unstructured":"Rudenko, O., Tkach, V., Berezin, V. & Bock, E. Detection of early behavioral markers of Huntington's disease in R6\/2 mice employing an automated social home cage. Behav. Brain Res. 203, 188\u2013199 (2009).","journal-title":"Behav. Brain Res."},{"key":"BFnrneurol2014206_CR157","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbr.2009.06.031","volume":"205","author":"FJ Bode","year":"2009","unstructured":"Bode, F. J. et al. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic \u03b1-receptor levels in a transgenic Huntington's disease rat model. Behav. Brain Res. 205, 175\u2013182 (2009).","journal-title":"Behav. Brain Res."},{"key":"BFnrneurol2014206_CR158","doi-asserted-by":"publisher","first-page":"e19965","DOI":"10.1371\/journal.pone.0019965","volume":"6","author":"S Pietropaolo","year":"2011","unstructured":"Pietropaolo, S., Delage, P., Cayzac, S., Crusio, W. E. & Cho, Y. H. Sex-dependent changes in social behaviors in motor pre-symptomatic R6\/1 mice. PLoS ONE 6, e19965 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR159","doi-asserted-by":"publisher","first-page":"e69993","DOI":"10.1371\/journal.pone.0069993","volume":"8","author":"DH Loh","year":"2013","unstructured":"Loh, D. H., Kudo, T., Truong, D., Wu, Y. & Colwell, C. S. The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep. PLoS ONE 8, e69993 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR160","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","volume":"30","author":"IJ Heuser","year":"1991","unstructured":"Heuser, I. J., Chase, T. N. & Mouradian, M. M. The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease. Biol. Psychiatry 30, 943\u2013952 (1991).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2014206_CR161","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","volume":"27","author":"PN Pallier","year":"2007","unstructured":"Pallier, P. N. et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J. Neurosci. 27, 7869\u20137878 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2014206_CR162","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","volume":"1279","author":"PN Pallier","year":"2009","unstructured":"Pallier, P. N. & Morton, A. J. Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease. Brain Res. 1279, 90\u201398 (2009).","journal-title":"Brain Res."},{"key":"BFnrneurol2014206_CR163","doi-asserted-by":"publisher","first-page":"e9077","DOI":"10.1371\/journal.pone.0009077","volume":"5","author":"NI Wood","year":"2010","unstructured":"Wood, N. I. et al. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. PLoS ONE 5, e9077 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR164","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","volume":"256","author":"NA Aziz","year":"2009","unstructured":"Aziz, N. A. et al. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J. Neurol. 256, 1961\u20131965 (2009).","journal-title":"J. Neurol."},{"key":"BFnrneurol2014206_CR165","doi-asserted-by":"crossref","unstructured":"Kalliolia, E. et al. Plasma melatonin is reduced in Huntington's disease. Mov. Disord. (2014).","DOI":"10.1002\/mds.26003"},{"key":"BFnrneurol2014206_CR166","doi-asserted-by":"publisher","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh, N. et al. Neuroendocrine disturbances in Huntington's disease. PLoS ONE 4, e4962 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2014206_CR167","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz, N. A. et al. Increased hypothalamic\u2013pituitary\u2013adrenal axis activity in Huntington's disease. J. Clin. Endocrinol. Metab. 94, 1223\u20131228 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2014206_CR168","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0006-8993(92)90927-2","volume":"580","author":"A Kalsbeek","year":"1992","unstructured":"Kalsbeek, A., Buijs, R. M., van Heerikhuize, J. J., Arts, M. & van der Woude, T. P. Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580, 62\u201367 (1992).","journal-title":"Brain Res."},{"key":"BFnrneurol2014206_CR169","first-page":"117","volume":"36","author":"DJ van Wamelen","year":"2013","unstructured":"van Wamelen, D. J. et al. Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease. Sleep 36, 117\u2013125 (2013).","journal-title":"Sleep"},{"key":"BFnrneurol2014206_CR170","doi-asserted-by":"crossref","first-page":"e00133","DOI":"10.1042\/AN20130042","volume":"6","author":"T Kudo","year":"2014","unstructured":"Kudo, T. et al. Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid. ASN Neuro 6, e00133 (2014).","journal-title":"ASN Neuro"},{"key":"BFnrneurol2014206_CR171","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.febslet.2014.06.005","volume":"588","author":"I Robinson","year":"2014","unstructured":"Robinson, I. & Reddy, A. B. Molecular mechanisms of the circadian clockwork in mammals. FEBS Lett. 588, 2477\u20132483 (2014).","journal-title":"FEBS Lett."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.206","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2014.206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:42:08Z","timestamp":1747140128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":171,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFnrneurol2014206"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2014.206","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]},"assertion":[{"value":"11 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}